Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001 Dec;83(3):466-71.
Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol. 2001 Oct 15;154(8):740-7.
Sorensen SV, Chambers M, Heyes AE. An economic model for the pharmacological management of advanced non-small cell lung cancer in the US. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2001. Cannes, France. [abstract] Value Health. 2001 Sep; 4(6):403.
Gutierrez LP, Maguire A. Prevalence estimation for rare neoplasms: chronic myeloid leukemia. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 26, 2001. Toronto, Canada.
Arana A, Gutierrez L, Garcia-Rodriguez LA, Perez-Gutthann S. Antiepileptics and liver, testes, cervix uteri and vulvar cancer: a cohort study. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 2001. Toronto, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2001 Aug; 10(supp 1):128.
Anderson H, Espinosa E, Lofts F, Meehan M, Hutchinson G, Price N, Heyes AE. Evaluation of the Chemotherapy Patient Monitor: an interactive tool for facilitating communication between patients and oncologists during the cancer consultation. Eur J Cancer Care (Engl). 2001 Jun;10(2):115-23.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy - Lung (FACT-L): analysis of ECOG 5592 data. Poster presented at the 7th Central European Lung Cancer Conference; June 2001. Prague, Czech Republic. [abstract] Lung Cancer. 2001 May; 32(Suppl 1):52.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the functional assessment of cancer therapy - lung (FACT-L): analysis of ecog 5592 data. Poster presented at the 37th Annual Meeting of the American Society of Clinical Oncology; May 2001. San Francisco, CA.
Neighbors DM, Bell TJ, Wilson J, Dodd SL. Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain. J Pain Symptom Manage. 2001 Feb 1;21(2):129-43. doi: 10.1016/s0885-3924(00)00247-5.
Sorensen HT, Pedersen L, Olsen JH, Rothman KJ. Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA. 2001 Jan 10;285(2):168-9.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Bonomi P, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy (lung) (FACT-L): analysis of ECOG 5592 data. Lung Cancer. 2001;373-6.
Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Age at natural menopause and the risk of developing invasive epithelial ovarian cancer. Obstet Gynecol. 2001;98(1):85-90.
Bonfill X, Marzo M, Pladevall-Vila M, Marti J, Emparanza JI. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev. 2001;(1):CD002943.